892414-51-6 Usage
Pyrrolopyridine ring system
The core structure of the compound, consisting of a pyrrole ring fused to a pyridine ring.
Chlorine atom
A halogen atom attached to the pyrrolopyridine ring at the 6-position, which can be used for further functionalization or can influence the compound's reactivity.
Nitro group
A -NO2 functional group attached to the pyrrolopyridine ring at the 4-position, which can act as a strong electron-withdrawing group and can be reduced or used in other reactions.
Trifluoromethyl group
A -CF3 functional group attached to the pyrrolopyridine ring at the 3-position, which is an electron-withdrawing group and can influence the compound's reactivity and stability.
Silyl-protected alcohol group
A -OTMS (trimethylsilyl) protecting group attached to a carbon atom at the 1-position, which can protect the alcohol group from unwanted reactions and can be removed when needed.
Ether linkage
An -O-CH3 functional group attached to the pyrrolopyridine ring at the 2-position, which can act as a linker between the compound and other molecules or functional groups.
Applications in pharmaceuticals, materials science, or organic synthesis
The various functional groups present in the compound can be manipulated and modified to produce different properties or reactivities, making it potentially useful in a variety of fields.
Check Digit Verification of cas no
The CAS Registry Mumber 892414-51-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,2,4,1 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 892414-51:
(8*8)+(7*9)+(6*2)+(5*4)+(4*1)+(3*4)+(2*5)+(1*1)=186
186 % 10 = 6
So 892414-51-6 is a valid CAS Registry Number.
892414-51-6Relevant articles and documents
Improved synthesis of the selective rho-kinase inhibitor 6-chloro-n4-{3,5-difluoro-4-[(3-methyl-1h-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl} pyrimidin-2,4-diamine
Schirok, Hartmut,Paulsen, Holger,Kroh, Walter,Chen, Gang,Gao, Ping
experimental part, p. 168 - 173 (2010/04/29)
A highly potent and selective Rho-kinase inhibitor containing a 7-azaindole moiety has been developed at Bayer Schering Pharma. Herein we disclose details of a significantly improved synthesis of the compound in 8.2% overall yield. Key aspects include cost and safety considerations and the uncommon use of a trifluoromethyl group with controllable reactivity as a masked methyl group.